# ADAM17 and Vascular Function in Diabetes

> **NCT04557228** · NA · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 36 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Phosphatidylserine

## Key facts

- **NCT ID:** NCT04557228
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-02-03
- **Final completion:** 2025-11-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557228, "ADAM17 and Vascular Function in Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04557228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*